Table 1

Estimated rapid-test sensitivity during three periods of observation

Test Used at Clinic

Total testing at clinic

Total Testing Positive at Clinic

Eligible Participants Enrolled in Study (%)

Established HIV infections detected by PCR/ELISA

Observed Testing Sensitivity (95% CI)


Test Brand 1

69

11

82.7%

5

68.7% (41.3%-89.0%)


Test Brand 2

(before quality improvement measures)

759

87

65.9%

6

93.5% (86.5%-97.6%)


Test Brand 2

(following quality improvement measures)

349

39

80.2%

2

95.1% (83.5%-99.4%)


Wolpaw et al. BMC Health Services Research 2010 10:73   doi:10.1186/1472-6963-10-73

Open Data